lobbying_filings: d79ac5d8-05d0-41a2-b1eb-c84d6b04bd5b
This data as json
| filing_uuid | filing_type | registrant_id | registrant_name | registrant_state | registrant_country | registrant_house_id | client_id | client_name | client_state | client_ppb_state | client_country | client_ppb_country | client_general_description | client_government_entity | filing_year | filing_period | received_date | amount_reported | is_amendment | is_no_activity | is_termination | affiliated_org_count |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| d79ac5d8-05d0-41a2-b1eb-c84d6b04bd5b | RR | 401016871 | REPUBLIC CONSULTING, LLC | FL | US | 196861 | AMGEN USA INC. | DC | US | US | Biotechnology healthcare products | 0 | 2013 | first_quarter | 2013-01-17T12:37:28.073000-05:00 | 0 | 0 | 0 | 0 |